[PDF][PDF] The Children's Hospital of Philadelphia Research Institute Impact Factor Report, FY2008
Fishbein I, Alferiev I, Bakay M, Stachelek SJ, Sobolewski P, Lai M, Choi H, Chen IW, Levy
RJ. Local delivery of gene vectors from bare-metal stents by use of a biodegradable …
RJ. Local delivery of gene vectors from bare-metal stents by use of a biodegradable …
An academic centre for gene therapy research with clinical grade manufacturing capability
KB Islam, P Blomberg, K Wikström… - Annals of …, 1997 - Taylor & Francis
Huddinge University Hospital is a major teaching hospital affiliated with the Karolinska
Institute in Southern Stockholm. For the past few years several groups have been working …
Institute in Southern Stockholm. For the past few years several groups have been working …
Gene therapy made difficult
PA Kingston, AM Heagerty - Heart, 1999 - heart.bmj.com
Your editorial states “...(t) his inflammatory response is... generally observed using the sort of
adenoviral loads needed to achieve expression of the transgene”. Undoubtedly, many early …
adenoviral loads needed to achieve expression of the transgene”. Undoubtedly, many early …
[引用][C] VASCULAR IMPLANTS'NEW WAVE
S In - 1990 - nature.com
BETHESDA, Md.-One may not naturally associate implantable medical devices-such as
artificial heartswith biotechnology, or even biology. And vascular grafts typically consist of …
artificial heartswith biotechnology, or even biology. And vascular grafts typically consist of …
Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia
QH Meng, W Jamal, SL Hart, JR McEwan - Human gene therapy, 2006 - liebertpub.com
Somatic gene transfer continues to have potential for the study and therapy of
cardiovascular disease. We have developed a modular, self-assembling, nonviral system …
cardiovascular disease. We have developed a modular, self-assembling, nonviral system …
[PDF][PDF] Activated az-Macroglobulin and Transforming Growth Factor-01 Induce a Synergistic Smooth Muscle Cell Proliferative Response
GA StoufferS, J LaMarreplI, SL GoniaspII, GK Owens - academia.edu
The role that soluble binding proteins might play in regulating transforming growth factor-81
(TGF-@ l)-induced growth of smooth muscle cells (SMC) is unknown. az-Macroglobulin …
(TGF-@ l)-induced growth of smooth muscle cells (SMC) is unknown. az-Macroglobulin …
Uso de um agente terapêutico e de um agente de intensificação de permeação intracelular
L Bender - 2023 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
50341876&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
50341876&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Growth of Human Blood Vessels in Severe Combined Immunodeficient Mice
The development of strategies for the treatment of angiogenesis-dependent diseases has
been greatly aided by the development of in vivo models of angiogenesis (1). These …
been greatly aided by the development of in vivo models of angiogenesis (1). These …
[PDF][PDF] 1201 Gene Transfer to Vascular Tissues and Cell Therapies
A Hall - core.ac.uk
Conclusions: This study suggests that mean plaque size stabilizes at 4 weeks after carotid
injury with no further increase at later time points. Furthermore, there appears to be a time …
injury with no further increase at later time points. Furthermore, there appears to be a time …
Periluminal Expression of a Secreted Transforming Growth Factor-? Type II Receptor Inhibits In-Stent Neointima Formation Following Adenovirus-Mediated Stent …
CE Appleby, P Ranjzad, PD Williams… - 1557 …, 2014 - escholar.manchester.ac.uk
Transforming growth factor-β1 (TGF-β1) has been shown unequivocally to enhance
neointima formation in carotid and ileo-femoral arteries. In our previous studies, however …
neointima formation in carotid and ileo-femoral arteries. In our previous studies, however …